- Home
- TAK vs SRE Comparison
TAK vs SRE Comparison
Compare TAK & SRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | SRE |
|---|---|---|
| Founded | 1781 | 1998 |
| Country | Japan | United States |
| Employees | 47455 | 15938 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4B | 60.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TAK | SRE |
|---|---|---|
| Price | $16.98 | $94.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $102.08 |
| AVG Volume (30 Days) | 2.9M | ★ 2.9M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.24% | 2.84% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.16 | $6.42 |
| Revenue Next Year | $1.22 | N/A |
| P/E Ratio | $41.25 | ★ $28.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $73.18 |
| 52 Week High | $18.90 | $101.04 |
Technical Indicators
Market Signals| Indicator | TAK | SRE |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 59.43 |
| Support Level | $15.88 | $90.20 |
| Resistance Level | $18.86 | $96.39 |
| Average True Range (ATR) | 0.23 | 1.57 |
| MACD | 0.18 | 0.23 |
| Stochastic Oscillator | 90.76 | 82.73 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About SRE DBA Sempra
Sempra serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. Sempra Infrastructure Partners, 25% owned by Sempra, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.